Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1999AIDS

Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJensa C. BellCenters for Disease Control and PreventionDRDavid N. RoseCleveland ClinicHSHenry S. SacksIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bell et al. (1999) studied this question.

synapsesocial.com/papers/6a16080640872a98d8b562d2https://doi.org/10.1097/00002030-199908200-00016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus1997 · 400 citations
  2. 2Updates of Cost of Illness and Quality of Life Estimates for Use in Economic Evaluations of HIV Prevention Programs1997 · 233 citations
  3. 3Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection1998 · 9,539 citations
  4. 4A Retrospective Cohort Study of the Risk of Tuberculosis Among Women of Childbearing Age with HIV Infection in Zaire1991 · 109 citations
  5. 5Isoniazid-associated Hepatitis Deaths: A Review of Available Information1992 · 204 citations